Arena Pharmaceuticals' Belviq Approval May Not Match The Hype [View article]
MR. ???????
“The main purpose of this article is to remind the individual investor of the potential risks of blindly jumping into a stock following FDA approval, without doing his/her homework first”
So why you didn't’t published it before when it was 1.5$ for instance It was much risky to invest at that time, and why people paid 13.5$ after approval?
“We are a champion of the individual investor, and we put their interests first”
What kind of champion??? with such low level article, that’s what you call “champions” (HA HA HA)?
“We are completely independent and objective in our analysis”
You need to be embarrassed, if you call this analysis article
“In this article, we pointed out a few companies that received similar hype and struggled thereafter. Arena, however, does have a commercialization partnership with Japanese pharmaceutical firm Eisai, which could give it a leg-up on other firms that struggled to commercialize drugs.”
This is not the main issue here, the main issue is the drug BELVIQ itself, and 19-4 super professionals that suggested to approve it. The rest will be done by big players in the industry, they will offer to buy the company almost certainly sooner (in very good price around 45-60$) then anyone think. Before EMA will approve it and nearby 4 month left
“We are optimistic on this partnership, which may mitigate risks to some degree, but they remain.”
Why you don’t give the risks???? I would suggest to you to do SWAT analysis for the company and give your conclusions, but with the level of your article I’m sure you can’t
“As many others have pointed out, this approval could launch new competition in the space.”
Competition is very good, but how do you explain the price of these Vivus’ Qnexa And Orexigen’s , it’s funny that you don’t even mentioned the bull in their prices, after ARNA the only one that received it without REMS or CRL. You sound that you know it will be approved, so let’s assume they will get it you will see Drop of 30% 10 min after approval????????????
“Vivus’ Qnexa will likely face FDA approval soon” and Orexigen’s Contrave could ultimately be approved.”
What is your arguments here, are you gamblers?????? Or independents with no interest?????
“Having a first-mover advantage often helps, but is not the end-all-be-all when determining a product’s success. The possibility for other more effective drugs to be created in this space cannot be ruled out.”
Technology always in progress, that’s why it took 13 years to approve the first one BELVIQ by ARNA. So tomorrow we’ll see on the shelves 5, 10, or 20 new drugs and the world will be out of obese people.
“We will continue to monitor developments, and we maintain our view that an unbiased, objective analysis that clearly points out risks is the best way to serve the individual investor.”
If I was you, I we’ll stop make jokes, and do not publish so called low level article.
Please see below the influence after 4 years with 5% success per year, and 10% success You will be notices that these people will become models after taking BELVIQ
ONLY 5 %PER YEAR
start Weight AFTER AFTER AFTER AFTER 0 1YEAR 2YEAR 3YEAR 4YEAR LOST lost% 400 380 361 342.95 325.80 74.20 18.55%lb 181.82 172.73 164.09 155.89 148.09 33.73 KG 18.55% 0.95 0.9025 0.857375 81.45%
ONLY 10 %PER YEAR start waight AFTER AFTER AFTER AFTER 0 1YEAR 2YEAR 3YEAR 4YEAR LOST lost% 400 360 324 291.6 262.44 137.56 lb 34.39% 181.82 163.64 147.27 132.55 119.29 62.53 KG 34.39% 0.9 0.81 0.729 65.61%
How To Think About Small To Mid Cap Biotech Firms: Profit-Taking On Arena [View article]
It's the same here
Arena Pharmaceuticals' Belviq Approval May Not Match The Hype [View article]
MR. ???????
“The main purpose of this article is to remind the individual investor of the potential risks of blindly jumping into a stock following FDA approval, without doing his/her homework first”
So why you didn't’t published it before when it was 1.5$ for instance
It was much risky to invest at that time, and why people paid 13.5$ after approval?
“We are a champion of the individual investor, and we put their interests first”
What kind of champion??? with such low level article, that’s what you call “champions” (HA HA HA)?
“We are completely independent and objective in our analysis”
You need to be embarrassed, if you call this analysis article
“In this article, we pointed out a few companies that received similar hype and struggled thereafter. Arena, however, does have a commercialization partnership with Japanese pharmaceutical firm Eisai, which could give it a leg-up on other firms that struggled to commercialize drugs.”
This is not the main issue here, the main issue is the drug BELVIQ itself, and 19-4 super professionals that suggested to approve it.
The rest will be done by big players in the industry, they will offer to buy the company almost certainly sooner (in very good price around 45-60$) then anyone think.
Before EMA will approve it and nearby 4 month left
“We are optimistic on this partnership, which may mitigate risks to some degree, but they remain.”
Why you don’t give the risks???? I would suggest to you to do SWAT analysis for the company
and give your conclusions, but with the level of your article I’m sure you can’t
“As many others have pointed out, this approval could launch new competition in the space.”
Competition is very good, but how do you explain the price of these Vivus’ Qnexa
And Orexigen’s , it’s funny that you don’t even mentioned the bull in their prices, after ARNA the only one that received it without REMS or CRL.
You sound that you know it will be approved, so let’s assume they will get it you will see
Drop of 30% 10 min after approval????????????
“Vivus’ Qnexa will likely face FDA approval soon” and Orexigen’s Contrave could ultimately be approved.”
What is your arguments here, are you gamblers?????? Or independents with no interest?????
“Having a first-mover advantage often helps, but is not the end-all-be-all when determining a product’s success.
The possibility for other more effective drugs to be created in this space cannot be ruled out.”
Technology always in progress, that’s why it took 13 years to approve the first one BELVIQ by ARNA.
So tomorrow we’ll see on the shelves 5, 10, or 20 new drugs and the world will be out of obese people.
“We will continue to monitor developments, and we maintain our view that an unbiased, objective analysis that clearly points out risks is the best way to serve the individual investor.”
If I was you, I we’ll stop make jokes, and do not publish so called low level article.
Please see below the influence after 4 years with 5% success per year, and 10% success
You will be notices that these people will become models after taking BELVIQ
ONLY 5 %PER YEAR
start Weight AFTER AFTER AFTER AFTER
0 1YEAR 2YEAR 3YEAR 4YEAR LOST lost%
400 380 361 342.95 325.80 74.20 18.55%lb
181.82 172.73 164.09 155.89 148.09 33.73 KG 18.55%
0.95 0.9025 0.857375 81.45%
350 332.5 315.875 300.08125 285.08 64.92 lb 18.55%
159.09 151.14 143.58 136.40 129.58 29.51 KG 18.55%
0.95 0.9025 0.857375 81.45%
300 285.00 270.75 257.21 244.35 55.65 lb 18.55%
136.36 129.55 123.07 116.91 111.07 25.29 KG 18.55%
95.00% 90.25% 85.74% 81.45%
200 190.00 180.50 171.48 162.90 37.10 lb 18.55%
90.91 86.36 82.05 77.94 74.05 16.86 KG 18.55%
95.00% 90.25% 85.74% 81.45%
150 142.50 135.38 128.61 122.18 27.82 lb 18.55%
68.18 64.77 61.53 58.46 55.53 12.65 KG 18.55%
95.00% 90.25% 85.74% 81.45%
ONLY 10 %PER YEAR
start waight AFTER AFTER AFTER AFTER
0 1YEAR 2YEAR 3YEAR 4YEAR LOST lost%
400 360 324 291.6 262.44 137.56 lb 34.39%
181.82 163.64 147.27 132.55 119.29 62.53 KG 34.39%
0.9 0.81 0.729 65.61%
350 315 283.5 255.15 229.635 120.37 lb 34.39%
159.09 143.18 128.86 115.98 104.38 54.71 KG 34.39%
0.9 0.81 0.729 65.61%
300 270.00 243.00 218.70 196.83 103.17 lb 34.39%
136.36 122.73 110.45 99.41 89.47 46.90 KG 34.39%
95.00% 90.25% 85.74% 81.45%
200 180 162 145.8 131.22 68.78 lb 34.39%
90.91 81.82 73.64 66.27 59.65 31.26 KG 34.39%
95.00% 90.25% 85.74% 81.45%
150 135 121.5 109.35 98.415 51.59 lb 34.39%
68.18 61.36 55.23 49.70 44.73 23.45 KG 34.39%
95.00% 90.25% 85.74% 81.45%
Arena Pharmaceuticals' Belviq Approval May Not Match The Hype [View article]
If I was you I we'll close my company
I never seen in my life such a low level of understanding
1 18-4 specialist gave green light to this drug
(what do you understand compare to them)
ONLY 5 %PER YEARstart waightAFTERAFTERAFTERA... 0.950.90250.85737581.45%350332.5315.875300.08125285.0864.92lb18.55%159.09151.14143.58136.40129.5829.51KG18.55% 0.950.90250.85737581.4... 95.00%90.25%85.74%81.45% 200190.00180.50171.481... 95.00%90.25%85.74%81.45%150142.50135.38128.61122.1827.82lb18.55%68.1864.7761.5358.4655.5312.65KG18.55% 95.00%90.25%85.74%81.45%
ONLY 10 %PER YEARstart weightAFTERAFTERAFTERA... 0.90.810.72965.61%350315283.5255.15229.635120.37lb34.39%159.09143.18128.86115.98104.3854.71KG34.39% 0.90.810.72965.61%3002... 95.00%90.25%85.74%81.45% 200180162145.8131.2268... 95.00%90.25%85.74%81.45%150135121.5109.3598.41551.59lb34.39%68.1861.3655.2349.7044.7323.45KG34.39% 95.00%90.25%85.74%81.45%
If it works like that most of the guys will become models
after 4 years
So if this is not thousand of bucks per person (sells)
compare to any cost of any treatment or surgery